NCT07126730
Effects of EXOPULSE Mollii Suit on Spasticity and Functionality in Multiple Sclerosis Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 11 words Show 7 more changesShow less
- Completed without a posted recruiting period
- Primary completion date changed from estimate of Jan 1, 2026 to Jun 1, 2026
- Enrollment target: estimated 30 to confirmed 31
- Study sites: 0 to 1
- Study completion date changed from estimate of Feb 1, 2026 to Jun 15, 2026
- Secondary endpoints: details revised at 10 of 10 entries
- Study description revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Modified Ashworth Scale (MAS)
Timeframe: 4 weeks
Berg Balance Scale (BBS)
Timeframe: 4 weeks
OptoGait Gait Analysis System
Timeframe: 4 weeks
Secondary (10)
EDSS (Expanded Disability Status Scale)
Visual Analog Scale (VAS) for pain and fatigue
Fatigue Severity Scale
9-Hole Peg Test
5 Times Sit to Stand Test
Show 5 moreShow less
Timed Up and Go (TUG) Test
10 meter Walk Test
12-Item Multiple Sclerosis Walking Scale
Functional Independence Measure (FIM)
Multiple Sclerosis Quality of Life-54 (MSQOL-54)
Arms and interventions
EXOPULSE Mollii + ExerciseExperimental
During the 60-minute EXOPULSE Mollii stimulation session, patients will also perform a guided exercise program.
EXOPULSE MolliiActive comparator
For 60 minutes, patients will only receive stimulation while wearing the EXOPULSE Mollii suit.
Devices: EXOPULSE Mollii Suit + Exercise, EXOPULSE Mollii Suit
Sites
1 site in 1 country
- Hacettepe UniversityAnkara, Samanpazari, Turkey (Türkiye)